 |
|
|
|
Pro-State 2
Fred Saad, M.D. and Robert Lerner, M.D.
Emerging therapies for castration-resistant prostate cancer. >
Fred Saad, M.D., is Professor, Chief of Urology and Director G-U Oncology, the University of Montreal Hospital Centers. He holds the University of Montreal Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer at the Montreal Cancer Institute. Robert Lerner, M.D., is Professor of Medicine and Vice Chair, New York Medical College.
-
Management of the post-myocardial infarction patient >
Richard Josephson, M.S., M.D., and Sri K. Madan Mohan, M.D.
-
New ways to prevent stroke in AFib patients >
Muhib Khan, M.D., and Karen Furie, M.D., M.P.H.
-
Unexplained bleeding in hospitalized patients. >
Meera B. Chitlur, M.D.
Terra Derma
Free CME: the biology and genetics of malignant melanoma >
|
Hollywood Arcade
Free CME: Metastatic breast cancer >
|
IPF
Free CME: Idiopathic Pulmonary Fibrosis >
|
Air Command
Free CME: Emerging therapies and strategies for lung cancer. >
|
